94 related articles for article (PubMed ID: 11296367)
1. [A case of LGMD2A identified with both western blot analysis and immunostaining of calpain 3 in biopsied muscle].
Ibi T; Jing L; Nakao N; Minami N; Sahashi K
Rinsho Shinkeigaku; 2000 Oct; 40(10):1023-7. PubMed ID: 11296367
[TBL] [Abstract][Full Text] [Related]
2. The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A.
Vainzof M; de Paula F; Tsanaclis AM; Zatz M
J Clin Pathol; 2003 Aug; 56(8):624-6. PubMed ID: 12890817
[TBL] [Abstract][Full Text] [Related]
3. Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients.
Hermanová M; Zapletalová E; Sedlácková J; Chrobáková T; Letocha O; Kroupová I; Zámecník J; Vondrácek P; Mazanec R; Maríková T; Vohánka S; Fajkusová L
Muscle Nerve; 2006 Mar; 33(3):424-32. PubMed ID: 16372320
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A.
Groen EJ; Charlton R; Barresi R; Anderson LV; Eagle M; Hudson J; Koref MS; Straub V; Bushby KM
Brain; 2007 Dec; 130(Pt 12):3237-49. PubMed ID: 18055493
[TBL] [Abstract][Full Text] [Related]
5. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.
Sáenz A; Leturcq F; Cobo AM; Poza JJ; Ferrer X; Otaegui D; Camaño P; Urtasun M; Vílchez J; Gutiérrez-Rivas E; Emparanza J; Merlini L; Paisán C; Goicoechea M; Blázquez L; Eymard B; Lochmuller H; Walter M; Bonnemann C; Figarella-Branger D; Kaplan JC; Urtizberea JA; Martí-Massó JF; López de Munain A
Brain; 2005 Apr; 128(Pt 4):732-42. PubMed ID: 15689361
[TBL] [Abstract][Full Text] [Related]
6. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.
Chrobáková T; Hermanová M; Kroupová I; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Stanek J; Havlová M; Fajkusová L
Neuromuscul Disord; 2004 Oct; 14(10):659-65. PubMed ID: 15351423
[TBL] [Abstract][Full Text] [Related]
7. Late-onset autosomal recessive limb-girdle muscular dystrophy with rimmed vacuoles.
Nakamura A; Yoshida K; Ikeda S
Clin Neurol Neurosurg; 2004 Mar; 106(2):122-8. PubMed ID: 15003303
[TBL] [Abstract][Full Text] [Related]
8. Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3.
Jenne DE; Kley RA; Vorgerd M; Schröder JM; Weis J; Reimann H; Albrecht B; Nürnberg P; Thiele H; Müller CR; Meng G; Witt CC; Labeit S
Biol Chem; 2005 Jan; 386(1):61-7. PubMed ID: 15843148
[TBL] [Abstract][Full Text] [Related]
9. [LGMD2A(calpain 3 deficiency)].
Kawai H
Ryoikibetsu Shokogun Shirizu; 2001; (35):79-83. PubMed ID: 11555997
[No Abstract] [Full Text] [Related]
10. cDNA analyses of CAPN3 enhance mutation detection and reveal a low prevalence of LGMD2A patients in Denmark.
Duno M; Sveen ML; Schwartz M; Vissing J
Eur J Hum Genet; 2008 Aug; 16(8):935-40. PubMed ID: 18337726
[TBL] [Abstract][Full Text] [Related]
11. Calpain 3 deficiency presenting as fibre type disproportion.
Vattemi G; Tonin P; Neri M; Marini M; Gualandi F; Guglielmi V; Ferlini A; Tomelleri G
Neuropathol Appl Neurobiol; 2009 Dec; 35(6):614-7. PubMed ID: 19490426
[No Abstract] [Full Text] [Related]
12. Multiplex Western blotting system for the analysis of muscular dystrophy proteins.
Anderson LV; Davison K
Am J Pathol; 1999 Apr; 154(4):1017-22. PubMed ID: 10233840
[TBL] [Abstract][Full Text] [Related]
13. High incidence of 550delA mutation of CAPN3 in LGMD2 patients from Russia.
Pogoda TV; Krakhmaleva IN; Lipatova NA; Shakhovskaya NI; Shishkin SS; Limborska SA
Hum Mutat; 2000 Mar; 15(3):295. PubMed ID: 10679950
[TBL] [Abstract][Full Text] [Related]
14. Muscle pathology in 31 patients with calpain 3 gene mutations.
Nadaj-Pakleza AA; Dorobek M; Nestorowicz K; Ryniewicz B; Szmidt-Sałkowska E; Kamińska AM
Neurol Neurochir Pol; 2013; 47(3):214-22. PubMed ID: 23821418
[TBL] [Abstract][Full Text] [Related]
15. Absence of calpain 3 in a form of limb-girdle muscular dystrophy (LGMD2A).
Spencer MJ; Tidball JG; Anderson LV; Bushby KM; Harris JB; Passos-Bueno MR; Somer H; Vainzof M; Zatz M
J Neurol Sci; 1997 Mar; 146(2):173-8. PubMed ID: 9077514
[TBL] [Abstract][Full Text] [Related]
16. [Case of LGMD2A (calpainopathy) clinically presenting as Miyoshi distal myopathy].
Shirafuji T; Otsuka Y; Kobessho H; Minami N; Hayashi Y; Nishino I; Kanda F
Rinsho Shinkeigaku; 2008 Sep; 48(9):651-5. PubMed ID: 19048948
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle.
Baghdiguian S; Richard I; Martin M; Coopman P; Beckmann JS; Mangeat P; Lefranc G
J Mol Med (Berl); 2001 Jun; 79(5-6):254-61. PubMed ID: 11485017
[TBL] [Abstract][Full Text] [Related]
18. Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype?
Pizzanelli C; Mancuso M; Galli R; Choub A; Fanin M; Nascimbeni AC; Siciliano G; Murri L
Neurol Sci; 2006 Jun; 27(2):134-6. PubMed ID: 16816913
[TBL] [Abstract][Full Text] [Related]
19. Myopathy with lobulated muscle fibers: evidence for heterogeneous etiology and clinical presentation.
Figarella-Branger D; El-Dassouki M; Saenz A; Cobo AM; Malzac P; Tong S; Cassotte E; Azulay JP; Pouget J; Pellissier JF
Neuromuscul Disord; 2002 Jan; 12(1):4-12. PubMed ID: 11731278
[TBL] [Abstract][Full Text] [Related]
20. Clinical, pathological, and genetic features of limb-girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families.
Kawai H; Akaike M; Kunishige M; Inui T; Adachi K; Kimura C; Kawajiri M; Nishida Y; Endo I; Kashiwagi S; Nishino H; Fujiwara T; Okuno S; Roudaut C; Richard I; Beckmann JS; Miyoshi K; Matsumoto T
Muscle Nerve; 1998 Nov; 21(11):1493-501. PubMed ID: 9771675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
